NASDAQ:INCR - Nasdaq - IL0011063760 - Common Stock - Currency: USD
NASDAQ:INCR (2/21/2025, 8:00:01 PM)
1.64
0 (-0.1%)
The current stock price of INCR is 1.64 USD. In the past month the price decreased by -4.99%. In the past year, price decreased by -13.23%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
LLY | ELI LILLY & CO | 67.21 | 829.40B | ||
NVO | NOVO-NORDISK A/S-SPONS ADR | 27.53 | 390.99B | ||
JNJ | JOHNSON & JOHNSON | 16.25 | 390.76B | ||
AZN | ASTRAZENECA PLC-SPONS ADR | 20.56 | 230.17B | ||
MRK | MERCK & CO. INC. | 11.71 | 226.40B | ||
NVS | NOVARTIS AG-SPONSORED ADR | 13.77 | 215.98B | ||
PFE | PFIZER INC | 8.46 | 149.04B | ||
SNY | SANOFI-ADR | 13.62 | 136.54B | ||
BMY | BRISTOL-MYERS SQUIBB CO | 48.97 | 113.23B | ||
GSK | GSK PLC-SPON ADR | 7.81 | 74.77B | ||
ZTS | ZOETIS INC | 27.1 | 72.39B | ||
TAK | TAKEDA PHARMACEUTIC-SP ADR | 31.95 | 44.58B |
InterCure Ltd. engages in the business of medical cannabis and biomedicine. Thorugh its wholly owned subsidiary Canndoc the Company operates as licensed cannabis producer and one of the first to offer Good Manufacturing Practices (GMP) certified and pharmaceutical-grade medical cannabis products.
INTERCURE LTD
Medinat HaYehudim 85
Herzliya 27604 IL
CEO: Alistair Macdonald
Employees: 270
Company Website: https://www.intercure.co/
Investor Relations: http://www.intercure.co/resources/investor-faqs
Phone: 972774605012
The current stock price of INCR is 1.64 USD. The price decreased by -0.1% in the last trading session.
The exchange symbol of INTERCURE LTD is INCR and it is listed on the Nasdaq exchange.
INCR stock is listed on the Nasdaq exchange.
INTERCURE LTD (INCR) has a market capitalization of 77.34M USD. This makes INCR a Micro Cap stock.
INTERCURE LTD (INCR) currently has 270 employees.
INTERCURE LTD (INCR) has a support level at 1.64 and a resistance level at 1.65. Check the full technical report for a detailed analysis of INCR support and resistance levels.
The Revenue of INTERCURE LTD (INCR) is expected to decline by -24.35% in the next year. Check the estimates tab for more information on the INCR EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
INCR does not pay a dividend.
INTERCURE LTD (INCR) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.38).
The outstanding short interest for INTERCURE LTD (INCR) is 0.14% of its float. Check the ownership tab for more information on the INCR short interest.
ChartMill assigns a technical rating of 3 / 10 to INCR. When comparing the yearly performance of all stocks, INCR turns out to be only a medium performer in the overall market: it outperformed 60.16% of all stocks.
ChartMill assigns a fundamental rating of 3 / 10 to INCR. INCR has a bad profitability rating. Also its financial health evaluation is rather negative.
Over the last trailing twelve months INCR reported a non-GAAP Earnings per Share(EPS) of -0.38. The EPS decreased by -237.58% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -7.88% | ||
ROE | -13.61% | ||
Debt/Equity | 0.23 |
ChartMill assigns a Buy % Consensus number of 83% to INCR. The Buy consensus is the average rating of analysts ratings from 7 analysts.
For the next year, analysts expect an EPS growth of 90.7% and a revenue growth -24.35% for INCR